NABI BIOPHARMACEUTICALS 4
4 · NABI BIOPHARMACEUTICALS · Filed Nov 3, 2003
Insider Transaction Report
Form 4
SMITH MARK L
Sr. VP Fin., CFO, CAO & Treas.
Transactions
- Other
Common Stock
2003-05-31$5.94/sh+1,706.64$10,140→ 14,337.077 total
Footnotes (1)
- [F1]Voluntarily reported acquisition under the issuer's 2000 Employee Stock Purchase Plan, which is an exempt transaction pursuant to Rule 16b-3(c).